| DYNAVAX TECHS DL-,001 |
| USA |
| Gesundheit |
| US2681582019 / A12EV9 |
| DYF1 (Frankfurt) / DVAX (NASDAQ) |
| FRA:DYF1, ETR:DYF1, DYF1:GR, NASDAQ:DVAX |
| - |
| http://www.dynavax.com/ |
|
Dynavax Technologies Corporation is a biopharmaceu..
>Volltext.. |
| 1534.12 Mio. EUR |
| 1228.4 Mio. EUR |
| 280.76 Mio. EUR |
| 15.87 Mio. EUR |
| -36.87 Mio. EUR |
| -0.28 EUR |
| 245.68 Mio. EUR |
| 136.12 Mio. EUR |
| 76.99 Mio. EUR |
| 6.06 |
| 20.24% |
| -301.1% |
| - |
| - |
| - |
| - |
| DYNAVAX |
| 29.12.25 |
|